Although molecular mechanisms linking obesity and cancer risk/prognosis are not fully elucidated, obesity creates a host environment characterized by low-grade systemic inflammation, disturbed sex steroid signalling and increased insulin/insulin-like growth factors that may promote malignant cell growth and progression. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.